The discovery and characterization of ML218: A novel, centrally active T-Type calcium channel inhibitor with robust effects in STN neurons and in a rodent model of Parkinson's disease
Zixiu Xiang, Analisa D. Thompson, John T. Brogan, Michael L. Schulte, Bruce J. Melancon, Debbie Mi, L. Michelle Lewis, Bende Zou, Liya Yang, Ryan Morrison, Tammy Santomango, Frank Byers, Katrina Brewer, Jonathan S. Aldrich, Haibo Yu, Eric S. Dawson, Min Li, Owen McManus, Carrie K. Jones, J. Scott DanielsCorey R. Hopkins, Ximin Simon Xie, P. Jeffrey Conn, C. David Weaver, Craig W. Lindsley
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'The discovery and characterization of ML218: A novel, centrally active T-Type calcium channel inhibitor with robust effects in STN neurons and in a rodent model of Parkinson's disease'. Together they form a unique fingerprint.